Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
never saw the answer to this as it was deleted
have you bought yet ex? genuinely curious
whatever, the SAP and new endpoints account for psPD now, and that's all that matters. of course things could have been smoother with a better design at the start. hindsight.
what matters now is that we'll pass primary and secondary with support from publication and share price will rocket. taking longer than anyone hoped but it'll happen and you know it.
nice recap, but imo your timeline is so off as to create another setup for disappointment. Sawston may well take until late January, publication + TLD could take until March or April, and approval might now happen until fall 2022 or sometime 2023. I have high confidence that things will play out as we expect, but I think it will take significantly longer than the timeline you’ve painted here.
I only say this so that when Jan/Feb rolls around with no big updates, there’s not another collective sense of dismay when in fact things are still going according to the (very slow but sure) plan.
i also find it hard to believe, with all those involved, that there’d be zero leak. $1 share price would mean zero leak. it’s surely a no-go on SNO.
but i’m still confident we’ll get positive results this winter, and $1 is a great buy price.
I don’t think any big players or even most retail investors actually expect anything at SNO, else we would be much higher than $1.04. When folks expected something at the last ASM/ASCO, there was a huge run to $2+, with the letdown and fall afterwards. No SNO run with no real expectation, and no real letdown or fall after imo.
what will it take for you to sell and move on with your life
he supposedly parsed out what would’ve been the control group by approximating it based on IMUC’s control. so he did his best to tease apart the ITT and placebo. But yeah the data would’ve matured which will help the tail, but still seems very close, which is why i’m confused at the responses the video got
no explanations for the apparent contradiction here?
senti/flipper/ other confident longs, help me see why there's no discrepancy in your thinking between senti's stickied post that says "The odds of them failing their primary and secondary endpoints are practically nil... especially with regards to the primary" and alphapuppy's video (
never mind
Why not Market Value of Listed Securities Standard, requiring closing price of $2, described on page 11 here: https://listingcenter.nasdaq.com/assets/initialguide.pdf
we just got a PR two weeks ago. sell if you’re not confident.
I’m in the same camp
Well, here’s the real reason for the Sawston delay. Thank you.
agreed. if people actually believed we’d get TLD next week, share price would be waaay higher.
I don’t think there’s any issues with the SAP or buy-in—that process took over a year and they wouldn’t have locked data without that being a shut case.
The reason for delay is likely that articles like this take an average of a year to publish, and a complicated trial like ours might take a bit longer. But, we’re within the likely range now, as it’s been about a year exactly from when they likely got data back from statisticians. In the meantime, FDA has been growing friendlier, manufacturing has been ramping up, Lancet article supports our strategy, the large loan repayment is behind us, etc etc.
I expect TLD, publication, and Sawston certification by end of January at the latest. If none of those three things happen by then I will consider shedding shares.
In three months max share price should be $4+, so I hardly care if we hit $1 again or even 87¢.
and the list of speakers hasn’t been changed since then?
can you provide a bit more to back that up?
huh? I see no mention of her
I hope Dave Innes sees this
sounds nice, but how does that jive with mgmt/DI saying they’re not releasing TLD at a conference and LL not being listed as a speaker?
Michael Bigger 11:07 pm EST tonight:
Pondering this equation Joe Burnett + Linda Liau + then some^1000 ... $CLPT $NWBO #DCVax #fireworks
Pondering this equation Joe Burnett + Linda Liau + then some^1000 ... $CLPT $NWBO #DCVax #fireworks
— Michael Bigger (@biggercapital) November 3, 2021
that wouldn’t include any naked shorting, right?
well, it's progress. slow, positive progress.
do you not see a connection between human cellular material and DCVax
okay this one you can bold
what makes you think this is algo buying?
ps no need to bold all of your posts
The high volume warrant shedding should be coming to an end. It was not a coincidence that many expired Nov 1, and a loan was due Nov 1. We survived the payback without closing under $1, and are now in the clear. Sawston, TLD, and blue skies ahead.
Warrant unloading to repay loan will likely continue through this week, then slow considerably along with the constant downward pressure. Should start to climb back up slowly middle of next week. Then Sawston and TLD on the menu for Nov-Dec.
NWBO only please
I was thinking of saying the same thing but didn’t bother to. If they don’t understand the basics of the SAP they shouldn’t be rambling on why NWBO is in trouble.
they've made ~$5M in the last month from warrant conversions, they're fine.
disagree. DI has said they're not waiting on anything and are trying to publish & PR as soon as possible. they're behind schedule on Sawston and they're behind schedule on publication, and will PR both as they come.
Why I think we'll be at a much higher share price in less than two months:
1. We broke out of 2020's flag about 4/5 of the way through by touching top of pennant, fading and hitting bottom, then launching out. We're now about 4/5 of the way through this bigger 2021 flag and just hit the top of the pennant then faded and are on bottom.
2. Although we're officially late on Sawston certification, chances are good that we have fixed / are fixing any issues and will be up and running in the next month (or two max). This could be a strong enough catalyst to launch us from current flag.
3. Even though it's frustrating that management chose to tie TLD to a publication, we are now closing in on the average time (~13 mo) for an oncology article to be published from data lock. I realize this is NOT the average time from lock to TLD, but we are in a scenario where TLD is married to publication, and so we are now in the zone of possible publication +TLD, and based on averages the chances of seeing something within two months is solid. Anticipation alone could launch us from flag.
4. The looming Nov 1 loans will be over soon and any fears of a dip from a raise will be gone.
5. The Lancet article was huge, both in terms of showing regulatory acceptance to NWBO's approach but also if it were the start of a succession of related articles, the gap between connected publications (even if not in Lancet) shouldn't be too large. IMO, this is another indication that our article will come in the next ~two months.
Most of us have been rewarded by our patience in the past, and I think patience will pay off big again by year's end.